178 related articles for article (PubMed ID: 2485904)
1. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
[TBL] [Abstract][Full Text] [Related]
2. The interaction of cholecystokinin and its fragments with norepinephrine in the circulatory system of diabetic rats.
Fiedorowicz RJ; Wiśniewski K
Pol J Pharmacol Pharm; 1989; 41(6):573-83. PubMed ID: 2577226
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
[TBL] [Abstract][Full Text] [Related]
4. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
5. The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
Wiśniewska RJ; Kupryszewski G
Pol J Pharmacol Pharm; 1992; 44(3):281-7. PubMed ID: 1470565
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
7. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart.
Wiśniewska R; Wiśniewski K
Rocz Akad Med Bialymst; 1996; 41(2):183-90. PubMed ID: 9020529
[TBL] [Abstract][Full Text] [Related]
8. Effects of dobutamine and acetylcholine on perfused hearts isolated from streptozocin-induced diabetic rats.
Sunagawa R; Nagamine F; Murakami K; Mimura G; Sakanashi M
Arzneimittelforschung; 1989 Apr; 39(4):470-4. PubMed ID: 2751733
[TBL] [Abstract][Full Text] [Related]
9. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats.
Wiśniewska RJ; Wiśniewski K
Gen Pharmacol; 1996 Jan; 27(1):159-63. PubMed ID: 8742514
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of secretin in intact rats versus rats with streptozotocin-induced diabetes mellitus.
Sitniewska E; Wiśniewska RJ
Pol J Pharmacol; 1999; 51(2):131-6. PubMed ID: 10425641
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nitric oxide in cardiovascular effects of cholecystokinin (CCK) in rats.
Wiśniewska RJ; Wiśniewski K
Rocz Akad Med Bialymst; 1998; 43():169-85. PubMed ID: 9972053
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
13. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
Fekete M; Penke B; Telegdy G
Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced type 1 diabetes mellitus.
Patel R; Shervington A; Pariente JA; Martinez-Burgos MA; Salido GM; Adeghate E; Singh J
Ann N Y Acad Sci; 2006 Nov; 1084():71-88. PubMed ID: 17151294
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin (CCK) and C-terminal fragments of CCK: effects of CCK-33, CCK-8 and CCK-4 in the cardiovascular system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Gen Pharmacol; 1996 Mar; 27(2):399-405. PubMed ID: 8919664
[TBL] [Abstract][Full Text] [Related]
16. Effects of brain natriuretic peptide on contraction and intracellular Ca2+ in ventricular myocytes from the streptozotocin-induced diabetic rat.
Howarth FC; Al-Shamsi N; Al-Qaydi M; Al-Mazrouei M; Qureshi A; Chandranath SI; Kazzam E; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():155-65. PubMed ID: 17151299
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.
Fossa AA; DePasquale MJ; Morrone J; Zorn SH; Bryce D; Lowe JA; McLean S
J Pharmacol Exp Ther; 1997 Apr; 281(1):180-7. PubMed ID: 9103496
[TBL] [Abstract][Full Text] [Related]
18. The effects of streptozotocin-induced diabetes and insulin-treatment on the cardiovascular system of the rat.
Pfaffman MA
Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):27-41. PubMed ID: 6994183
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholecystokinin, caerulein and pentagastrin on arterial blood pressure and plasma renin activity in rats.
Wiśniewska RJ
Pol J Pharmacol; 1997; 49(6):419-23. PubMed ID: 9566045
[TBL] [Abstract][Full Text] [Related]
20. Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats.
Paulson DJ; Kopp SJ; Tow JP; Peace DG
J Pharmacol Exp Ther; 1987 Feb; 240(2):529-34. PubMed ID: 3543300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
